#2020-535Ordinance No. 2020-535 Extending Drug Control Laws in Overseas Territories
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This ordinance extends drug control laws to France's overseas regions including Saint-Barthélemy, Saint-Pierre-et-Miquelon, Wallis and Futuna, French Polynesia, and New Caledonia. It aligns these regions with mainland France's regulations regarding the production and trade of substances that could be used to manufacture drugs. Businesses in these areas must now comply with the regulatory framework applicable in mainland France, impacting those involved in the manufacture and trade of potential drug precursors.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Extension of mainland France's drug control laws to overseas regions.
- Alignment of drug precursor regulations with mainland France.
- Impact on businesses engaged in the trade of chemical substances.
Obligations
What this law requires
Businesses in Saint-Barthélemy, Saint-Pierre-et-Miquelon, Wallis and Futuna, French Polynesia, and New Caledonia involved in the manufacture and trade of drug precursors must comply with EU Regulation (CE) n° 273/2004 (Articles 1-10, 14) as applied in mainland France
Businesses in specified overseas territories must comply with EU Regulation (CE) n° 111/2005 regarding surveillance of drug precursor trade between the Community and third countries, as applied in mainland France
Businesses must identify and monitor substances listed in Annex I of Regulation (CE) n° 273/2004 and the Annex of Regulation (CE) n° 111/2005 according to mainland France rules
Maintain documentation and record-keeping requirements for drug precursor transactions in accordance with Articles 3-6 and Article 1 of Regulation (CE) n° 1277/2005 as applied in mainland France
Report suspicious orders and transactions of drug precursors to competent authorities in accordance with Article 14 of Regulation (CE) n° 273/2004 and Articles 4-8 of Regulation (CE) n° 111/2005 as applied in mainland France